Validation of dynamic [18F]FE-PE2I PET for estimation of relative regional cerebral blood flow: a comparison with [15O]H2O PET
Abstract Background Dopamine transporter (DAT) imaging is used in the diagnostic work-up in suspected parkinsonian syndromes and dementia with Lewy bodies but cannot differentiate between these syndromes, and an extra brain imaging examination of the regional cerebral blood flow (rCBF) or glucose me...
Main Authors: | Susanna Jakobson Mo, Jan Axelsson, Lars Stiernman, Katrine Riklund |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2022-11-01
|
Series: | EJNMMI Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13550-022-00941-8 |
Similar Items
-
System evaluation of automated production and inhalation of 15O-labeled gaseous radiopharmaceuticals for the rapid 15O-oxygen PET examinations
by: Satoshi Iguchi, et al.
Published: (2018-12-01) -
Differences in Hemodynamic Alteration between Atherosclerotic Occlusive Lesions and Moyamoya Disease: A Quantitative <sup>15</sup>O-PET Study
by: Chiaki Igarashi, et al.
Published: (2021-10-01) -
Effect of DL-Methylephedrine on Dopamine Transporter Using Positron Emission Tomography With [18F]FE-PE2I
by: Tsuyoshi Nogami, et al.
Published: (2022-05-01) -
[18F]FE-PE2I DAT correlates with Parkinson’s disease duration, stage, and rigidity/bradykinesia scores: a PET radioligand validation study
by: Vera S. Kerstens, et al.
Published: (2023-04-01) -
[18F]FE-PE2I PET is a feasible alternative to [123I]FP-CIT SPECT for dopamine transporter imaging in clinically uncertain parkinsonism
by: Lisbeth Marner, et al.
Published: (2022-09-01)